USGIU
TMO icon

U.S. Global Investors (USGI)’s Thermo Fisher Scientific TMO Stock Holding History

U.S. Global Investors (USGI)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-300
Closed -$140K – 187
2020
Q4 		$140K Hold
300
– – 0.01% 143
2020
Q3 		$132K Buy
+300
New +$124K 0.01% 136

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Global Investors (USGI)'s TMO Position: Q1 2021 in Review

U.S. Global Investors (USGI) sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 300 shares — an estimated $140K sold.

U.S. Global Investors (USGI) first reported a position in TMO in Q3 2020 and held it in 2 quarters. The position peaked at $140K in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • U.S. Global Investors (USGI) reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 300 Thermo Fisher Scientific shares in Q1 2021, an estimated $140K.
  • U.S. Global Investors (USGI) first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 2 quarters.
  • U.S. Global Investors (USGI)'s Thermo Fisher Scientific position peaked at $140K in Q4 2020.
  • 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2021, filed 23 Apr 2021.